I think the idea of a new nic would have been a fresh start.
Why bother otherwise?
Quite obviously, if people can recognise you (and they have!) it might be time to reconsider your approach.
I'm looking for any content in your posts which show you understand where the company is at right now.
And where the future is for SAVR and TAVR.
Ann: SAVR Clinical Trial, page-73
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.99 |
Change
-0.910(8.35%) |
Mkt cap ! $211.1M | |||
| Open | High | Low | Value | Volume |
| $10.50 | $10.79 | $9.30 | $1.477M | 149.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $9.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.99 | 1999 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |